LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

Neogen Corp

Fermé

SecteurSoins de santé

6.19 2.48

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.92

Max

6.23

Chiffres clés

By Trading Economics

Revenu

649M

36M

Ventes

-16M

209M

P/E

Moyenne du Secteur

657.5

77.256

BPA

0.05

Marge bénéficiaire

17.371

Employés

2,974

EBITDA

667M

89M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+35.26% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

143M

1.4B

Ouverture précédente

3.71

Clôture précédente

6.19

Sentiment de l'Actualité

By Acuity

28%

72%

70 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Neogen Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 nov. 2025, 23:51 UTC

Résultats

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 nov. 2025, 23:10 UTC

Résultats

DBS Third Quarter Net Dips 2.0%

5 nov. 2025, 22:55 UTC

Résultats

Arm Holdings 2Q Profit Climbs on Record Demand

5 nov. 2025, 22:23 UTC

Résultats

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 nov. 2025, 23:52 UTC

Résultats

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 nov. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 nov. 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 nov. 2025, 23:12 UTC

Résultats

Nutrien 3Q Adj EPS 97c >NTR.T

5 nov. 2025, 23:11 UTC

Résultats

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q Sales $6.01B >NTR.T

5 nov. 2025, 23:10 UTC

Market Talk
Résultats

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q EPS 96c >NTR.T

5 nov. 2025, 23:04 UTC

Résultats

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 nov. 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 nov. 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 nov. 2025, 22:55 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 nov. 2025, 22:51 UTC

Résultats

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 nov. 2025, 22:50 UTC

Résultats

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 nov. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov. 2025, 22:43 UTC

Market Talk
Résultats

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 nov. 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 nov. 2025, 22:12 UTC

Acquisitions, Fusions, Rachats

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer Responds to Delaware Chancery Court Ruling

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Comparaison

Variation de prix

Neogen Corp prévision

Objectif de Prix

By TipRanks

35.26% hausse

Prévisions sur 12 Mois

Moyen 8.17 USD  35.26%

Haut 10 USD

Bas 6.5 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

1

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

5.17 / 5.99Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

70 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat